VACC - Vaccitech plc

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 89.35M
Enterprise value -96.26M
Trailing P/E 16.64
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.99
Price/book (mrq)0.37
Enterprise value/revenue -3.19
Enterprise value/EBITDA 6.38

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3-43.37%
S&P500 52-week change 31.77%
52-week high 37.4500
52-week low 32.0200
50-day moving average 32.4102
200-day moving average 32.8491

Share statistics

Avg vol (3-month) 356.82k
Avg vol (10-day) 339.13k
Shares outstanding 538.37M
Implied shares outstanding 6N/A
Float 826.9M
% held by insiders 126.37%
% held by institutions 126.99%
Shares short (14 May 2023) 420.41k
Short ratio (14 May 2023) 41.69
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.05%
Shares short (prior month 13 Apr 2023) 423.89k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -51.19%
Operating margin (ttm)-82.35%

Management effectiveness

Return on assets (ttm)-5.66%
Return on equity (ttm)-6.36%

Income statement

Revenue (ttm)30.15M
Revenue per share (ttm)0.81
Quarterly revenue growth (yoy)-96.90%
Gross profit (ttm)N/A
EBITDA -23.45M
Net income avi to common (ttm)-15.43M
Diluted EPS (ttm)-0.4000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)191.33M
Total cash per share (mrq)4.99
Total debt (mrq)10.65M
Total debt/equity (mrq)4.56
Current ratio (mrq)16.74
Book value per share (mrq)6.19

Cash flow statement

Operating cash flow (ttm)-11.03M
Levered free cash flow (ttm)5.66M